Loading...

Gilead Sciences, Inc.

GILDNASDAQ
Healthcare
Drug Manufacturers - General
$116.20
$3.00(2.65%)

Gilead Sciences, Inc. (GILD) Stock Overview

Explore Gilead Sciences, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

B+

Score: 79.2/100

Key Financials

Market Cap144.5B
P/E Ratio24.30
EPS (TTM)$7.74
ROE0.32%
Fundamental Analysis

AI Price Forecasts

1 Week$111.75
1 Month$117.47
3 Months$119.44
1 Year Target$104.80

GILD Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Gilead Sciences, Inc. (GILD) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 64.24, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $104.80.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 24.30 and a market capitalization of 144.5B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

Frequently Asked Questions

;